Tag: Afrezza

Image Source: MannKind Corporation (Screenshot)

MannKind Corporation Skyrockets On Sanofi Agreement

MannKind shares surged 33.12% to $0.620 on Thursday after the company announced a settlement agreement with French drugmaker Sanofi. The biotech company said that Sanofi’s affiliate Aventisub has agreed to terminate the promissory note and security agreement with MannKind. Aventisub […]

MannKind Corporation Stock Soars, But Why?

MannKind Corporation Stock Soars, But Why?

Shares in biopharmaceutical company MannKind Corporation were up more than 20% at 10:30 am ET. The company announced a special conference call with investors in which it would reveal more about plans to commercialize Afrezza (insulin human) inhalation powder. MannKind […]